Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
|
J Immunol
|
2006
|
2.44
|
2
|
Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis.
|
N Engl J Med
|
2003
|
2.12
|
3
|
Quality of life in patients with psoriasis: a systematic literature review.
|
J Investig Dermatol Symp Proc
|
2004
|
1.95
|
4
|
How good are clinical severity and outcome measures for psoriasis?: quantitative evaluation in a systematic review.
|
J Invest Dermatol
|
2009
|
1.87
|
5
|
The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review.
|
Arch Dermatol
|
2002
|
1.84
|
6
|
Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis.
|
Arch Dermatol
|
2010
|
1.77
|
7
|
Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis.
|
PLoS One
|
2010
|
1.73
|
8
|
Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy.
|
J Invest Dermatol
|
2011
|
1.71
|
9
|
Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients.
|
J Invest Dermatol
|
2006
|
1.62
|
10
|
Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
|
J Invest Dermatol
|
2009
|
1.56
|
11
|
Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition.
|
J Immunol
|
2007
|
1.55
|
12
|
Formation of fibrosis after nonablative and ablative fractional laser therapy.
|
Dermatol Surg
|
2011
|
1.41
|
13
|
UVB 311 nm tolerance of vitiligo skin increases with skin photo type.
|
Acta Derm Venereol
|
2005
|
1.40
|
14
|
Alefacept treatment in psoriatic arthritis: reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritis.
|
Arthritis Rheum
|
2002
|
1.22
|
15
|
Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
|
Pediatrics
|
2002
|
1.22
|
16
|
Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls.
|
Eur J Cell Biol
|
2002
|
1.14
|
17
|
Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
|
Arthritis Res Ther
|
2004
|
1.09
|
18
|
The burden of vitiligo: patient characteristics associated with quality of life.
|
J Am Acad Dermatol
|
2009
|
1.07
|
19
|
Skin barrier function in healthy subjects and patients with atopic dermatitis in relation to filaggrin loss-of-function mutations.
|
J Invest Dermatol
|
2010
|
1.04
|
20
|
Overview of psoriasis.
|
Dermatol Ther
|
2004
|
1.04
|
21
|
Benzoyl peroxide/clindamycin/UVA is more effective than fluticasone/UVA in progressive macular hypomelanosis: a randomized study.
|
J Am Acad Dermatol
|
2006
|
0.97
|
22
|
Langerhans cells favor skin flora tolerance through limited presentation of bacterial antigens and induction of regulatory T cells.
|
J Invest Dermatol
|
2013
|
0.95
|
23
|
T-cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapy.
|
Clin Cancer Res
|
2011
|
0.92
|
24
|
Digital image analysis for the evaluation of the inflammatory infiltrate in psoriasis.
|
Arch Dermatol Res
|
2005
|
0.91
|
25
|
Nonablative 1550-nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled pilot study.
|
J Am Acad Dermatol
|
2011
|
0.90
|
26
|
Low systemic exposure after repeated topical application of Pimecrolimus (Elidel), SD Z ASM 981) in patients with atopic dermatitis.
|
Dermatology
|
2002
|
0.90
|
27
|
Increased frequencies of IL-31-producing T cells are found in chronic atopic dermatitis skin.
|
Exp Dermatol
|
2012
|
0.89
|
28
|
Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: A systematic review.
|
J Am Acad Dermatol
|
2003
|
0.89
|
29
|
T cells in psoriatic lesional skin that survive conventional therapy with NB-UVB radiation display reduced IFN-gamma expression.
|
Arch Dermatol Res
|
2004
|
0.89
|
30
|
The burden of psoriasis is not determined by disease severity only.
|
J Investig Dermatol Symp Proc
|
2004
|
0.89
|
31
|
Alefacept therapy reduces the effector T-cell population in lesional psoriatic epidermis.
|
Arch Dermatol Res
|
2004
|
0.88
|
32
|
Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG.
|
PLoS One
|
2010
|
0.88
|
33
|
Clinical differences between atopic and atopiform dermatitis.
|
J Am Acad Dermatol
|
2008
|
0.87
|
34
|
Etanercept: an overview of dermatologic adverse events.
|
Arch Dermatol
|
2011
|
0.87
|
35
|
The course of life of patients with childhood atopic dermatitis.
|
Pediatr Dermatol
|
2009
|
0.86
|
36
|
Validation and refinement of the Millennium Criteria for atopic dermatitis.
|
J Dermatol
|
2011
|
0.86
|
37
|
Costs of treatment in patients with moderate to severe plaque psoriasis: economic analysis in a randomized controlled comparison of methotrexate and cyclosporine.
|
Arch Dermatol
|
2004
|
0.86
|
38
|
Expression of terminal complement components by human keratinocytes.
|
Mol Immunol
|
2007
|
0.85
|
39
|
Human keratinocytes produce the complement inhibitor factor I: Synthesis is regulated by interferon-gamma.
|
Mol Immunol
|
2007
|
0.83
|
40
|
High prevalence of autoimmune thyroiditis in children and adolescents with vitiligo.
|
Horm Res Paediatr
|
2013
|
0.83
|
41
|
Ultraviolet B radiation induces a transient appearance of IL-4+ neutrophils, which support the development of Th2 responses.
|
J Immunol
|
2002
|
0.83
|
42
|
Non-ablative 1,550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled split-face study.
|
Lasers Surg Med
|
2010
|
0.82
|
43
|
Wet work and hand eczema in apprentice nurses; part I of a prospective cohort study.
|
Contact Dermatitis
|
2013
|
0.82
|
44
|
Proceedings of the 4th Georg Rajka International Symposium on Atopic Dermatitis, Arcachon, France, September 15-17, 2005.
|
J Allergy Clin Immunol
|
2006
|
0.82
|
45
|
Neutrophils infiltrating ultraviolet B-irradiated normal human skin display high IL-10 expression.
|
Arch Dermatol Res
|
2004
|
0.82
|
46
|
Non-ablative 1550 nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a pilot study.
|
J Dermatolog Treat
|
2011
|
0.82
|
47
|
Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor.
|
Arch Dermatol Res
|
2007
|
0.82
|
48
|
Aberrant function of peripheral blood myeloid and plasmacytoid dendritic cells in atopic dermatitis patients.
|
J Allergy Clin Immunol
|
2008
|
0.82
|
49
|
Postelicitation model of allergic contact dermatitis for predicting the efficacy of topical drugs.
|
Exp Dermatol
|
2008
|
0.82
|
50
|
Human keratinocytes produce the complement inhibitor factor H: synthesis is regulated by interferon-gamma.
|
Mol Immunol
|
2005
|
0.81
|
51
|
Ultraviolet-B irradiation decreases IFN-gamma and increases IL-4 expression in psoriatic lesional skin in situ and in cultured dermal T cells derived from these lesions.
|
Exp Dermatol
|
2003
|
0.81
|
52
|
In situ demonstration of CD40- and CD154-positive cells in psoriatic lesions and keratinocyte production of chemokines by CD40 ligation in vitro.
|
J Pathol
|
2004
|
0.80
|
53
|
Recombinantly engineered human proteins: transforming the treatment of psoriasis.
|
Clin Immunol
|
2002
|
0.80
|
54
|
Tertiary teledermatology: a systematic review.
|
Telemed J E Health
|
2010
|
0.80
|
55
|
Ablative fractional laser therapy as treatment for Becker nevus: a randomized controlled pilot study.
|
J Am Acad Dermatol
|
2011
|
0.79
|
56
|
Suppression of different phases of systemic contact hypersensitivity by urocanic acid oxidation products.
|
Photochem Photobiol
|
2004
|
0.79
|
57
|
Progressive macular hypomelanosis is associated with a putative Propionibacterium species.
|
J Invest Dermatol
|
2009
|
0.79
|
58
|
Expression of IL-20 in synovium and lesional skin of patients with psoriatic arthritis: differential response to alefacept treatment.
|
Arthritis Res Ther
|
2012
|
0.79
|
59
|
Remission of incapacitating acute cutaneous lupus erythematosus in a patient with systemic lupus erythematosus by B cell-depletive therapy.
|
J Clin Rheumatol
|
2010
|
0.78
|
60
|
Characteristics of patients with universal vitiligo and health-related quality of life.
|
Arch Dermatol
|
2008
|
0.77
|
61
|
Analysis of risk factors in psoriatic patients with methotrexate-induced increases in transaminase levels.
|
Arch Dermatol
|
2004
|
0.77
|
62
|
Long-term management of plaque psoriasis with continuous efalizumab therapy.
|
J Am Acad Dermatol
|
2006
|
0.77
|
63
|
Increased incidence of hypercoagulability in patients with leg ulcers caused by leukocytoclastic vasculitis.
|
J Am Acad Dermatol
|
2004
|
0.77
|
64
|
UVB irradiation of normal human skin favors the development of type-2 T-cells in vivo and in primary dermal cell cultures.
|
Photochem Photobiol
|
2002
|
0.77
|
65
|
Smallpox: what the dermatologist should know.
|
Skinmed
|
2004
|
0.76
|
66
|
Filaggrin loss-of-function mutations and atopic dermatitis as risk factors for hand eczema in apprentice nurses: part II of a prospective cohort study.
|
Contact Dermatitis
|
2013
|
0.76
|
67
|
A prospective, randomized, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on lesional and nonlesional skin.
|
Dermatology
|
2012
|
0.76
|
68
|
The course of chronic plaque-type psoriasis in placebo groups of randomized controlled studies.
|
Arch Dermatol
|
2004
|
0.76
|
69
|
Blood concentrations of pimecrolimus in adult patients with atopic dermatitis following intermittent administration of pimecrolimus cream 1% (Elidel) for up to 1 year.
|
J Dermatolog Treat
|
2007
|
0.76
|
70
|
Proliferating prevalence of concepts and controversies in atopic eczema.
|
J Cosmet Dermatol
|
2004
|
0.75
|
71
|
The use of patch tests in determining hypersensitivity to etanercept and infliximab.
|
Arch Dermatol
|
2008
|
0.75
|
72
|
The atopic epidemic and the humidity hypothesis.
|
J Cosmet Dermatol
|
2004
|
0.75
|
73
|
A pilot study on tertiary teledermatology: feasibility and acceptance of telecommunication among dermatologists.
|
J Telemed Telecare
|
2010
|
0.75
|
74
|
Rudi Harold Cormane (1925-1987): a fabulous researcher and clinician.
|
Clin Dermatol
|
2009
|
0.75
|
75
|
IL-4 expression by neutrophils in psoriasis lesional skin upon high-dose UVB exposure.
|
Dermatology
|
2003
|
0.75
|
76
|
Cyclosporin A and methotrexate are equally effective in reducing T cell numbers in psoriatic skin lesions but have no consistent effect on IFN-gamma and IL-4 expression in psoriatic skin in situ.
|
Arch Dermatol Res
|
2002
|
0.75
|
77
|
Reduction of different inflammatory cell types of the innate immune system in psoriatic skin during etanercept treatment.
|
Exp Dermatol
|
2010
|
0.75
|
78
|
Evaluation of a clinical guideline for the diagnoses of physical and chronic urticaria and angioedema.
|
Acta Derm Venereol
|
2002
|
0.75
|